EN
e-Shop
Find A Doctor
Request an Appointment
International Patient
Emergency Contact
Hospitals
Specialties & Packages
Our Services
Health Hub
Patients & Visitors
Rotavirus is a highly contagious virus that remains one of the leading causes of acute gastroenteritis among infants and young children globally. The infection is marked by symptoms such as severe diarrhoea, vomiting, and fever. While many children recover at home with proper hydration, severe cases can result in dangerous dehydration requiring hospitalisation. The introduction of the rotavirus vaccine has dramatically reduced the incidence and severity of these infections, especially in vulnerable populations with limited access to healthcare and clean water.
The rotavirus vaccine significantly lowers the likelihood of children developing severe symptoms such as intense diarrhoea and dehydration. Vaccinated children are far less likely to require medical intervention or hospital admission due to rotavirus-related complications.
Vaccination has led to a notable decline in hospitalisations related to rotavirus infections. This not only benefits children and families but also eases the strain on healthcare services by reducing the number of cases requiring emergency care and inpatient treatment.
In areas where healthcare access is limited, rotavirus can be fatal. Vaccination has been shown to substantially reduce mortality rates linked to severe dehydration caused by the virus, particularly in low-resource settings.
High vaccination coverage within a population can reduce overall virus transmission, thereby offering indirect protection—known as herd immunity—to individuals who cannot be vaccinated for medical reasons.
The rotavirus vaccine is widely considered safe and well-tolerated. Most side effects, such as mild diarrhoea or temporary irritability, are short-lived and non-severe.
International health organisations such as the World Health Organization (WHO) and the Centres for Disease Control and Prevention (CDC) endorse the use of RotaTeq and Rotarix vaccines. Both have demonstrated efficacy rates exceeding 85% in preventing severe rotavirus disease and have undergone rigorous clinical trials confirming their safety.
After market approval, the vaccine continues to be closely monitored for any adverse effects. While an extremely rare association has been observed between the vaccine and intussusception (a form of bowel obstruction), the benefits of immunisation substantially outweigh this minimal risk. Healthcare providers are encouraged to discuss any concerns with parents prior to vaccination.
Unlike most vaccines, the rotavirus vaccine is administered orally. It contains live, attenuated strains of the virus that help the body’s immune system build protection without causing illness.
Upon ingestion, the vaccine activates immune cells in the gut, prompting the production of antibodies. These antibodies enable the body to mount a rapid and effective defence if exposed to the virus in the future. The resulting immunity is both immediate and long-lasting.
Widespread vaccination has led to a sharp reduction in both the number and severity of rotavirus cases. Countries with robust immunisation programmes have reported significantly fewer hospital visits and deaths due to the virus.
The rotavirus vaccine is a crucial measure in safeguarding the health of infants and young children. Its proven ability to prevent serious illness and reduce hospital admissions makes it a valuable addition to any child’s immunisation schedule.
At Gleneagles Hospitals, we prioritise your child’s wellbeing with comprehensive vaccination services supported by highly qualified medical professionals. For further information or to arrange a vaccination appointment, please visit our website, or download the MyHealth360 application from the Google Play Store or Apple App Store. Our commitment to patient safety and clinical excellence ensures your family receives the highest standard of care.
1.Immunization, Vaccines and Biologicals. (n.d.). Immunization, Vaccines and Biologicals. Retrieved January 24, 2025, from https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/rotavirus
2.Rotavirus Vaccination: For Providers. (n.d.). CDC. Retrieved January 24, 2025, from https://www.cdc.gov/vaccines/vpd/rotavirus/hcp/index.html
3.Rotavirus Vaccination | Rotavirus. (2024, July 19). CDC. Retrieved January 24, 2025, from https://www.cdc.gov/rotavirus/vaccines/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fvpd%2Frotavirus%2Fpublic%2Findex.html
Wait a minute
